Prompt
What's the most cost-effective way to expand variant detection using a digital PCR platform?
Latest observation
The most cost-effective way is usually to use digital PCR only for the variants you truly need to confirm, and design the assay to be as multiplexed and reusable as possible.
Practical cost-saving approach
-
Start with a targeted shortlist
- Use sequencing or prior screening to identify the few variants worth tracking.
- Digital PCR is cheapest when it’s used for focused, high-value validation or monitoring, not broad discovery.
-
Design duplex or multiplex assays
- Run wild-type + mutant in the same reaction when possible.
- This cuts reagent use, chip/well consumption, and hands-on time.
-
Use shared assay scaffolds
- If you’re expanding to multiple variants in the same gene or region, try to reuse:
- the same primers
- the same PCR conditions
- different probes only where necessary
- This lowers development and optimization costs.
- If you’re expanding to multiple variants in the same gene or region, try to reuse:
-
Prioritize high-throughput sample batching
- The platform becomes more economical when many samples are run per assay setup.
- Batch samples to reduce per-sample labor and instrument time.
-
Use digital PCR for screening, not full panel replacement
- For large numbers of variants, a cheaper workflow is often:
- NGS for broad discovery
- digital PCR for targeted confirmation/monitoring
- Replacing NGS entirely with dPCR usually gets expensive fast if you keep adding many separate assays.
- For large numbers of variants, a cheaper workflow is often:
-
Choose the right chemistry and platform format
- Some platforms are more cost-efficient for:
- low assay counts but lots of samples
- or moderate multiplexing
- The most economical option depends on whether your bottleneck is assay count, sample count, or reaction cost.
- Some platforms are more cost-efficient for:
Bottom line
If your goal is to expand variant detection cost-effectively, the best strategy is usually: multiplex targeted digital PCR assays for a small set of clinically or experimentally important variants, ideally after an initial broad screen by sequencing.
If you want, I can also help compare digital PCR vs qPCR vs targeted NGS for your specific use case.